Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
39,95 Prices may be subject to local taxes which are calculated during checkout Similar content being viewed by others References de la Peyronie, F
Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that has transformed metabolic disease treatment
Both semaglutide and Mounjaro fall into the category of GLP-1 receptor agonists, meaning they mimic a hormone that helps regulate blood sugar, digestion, and appetite
Adults with Obesity: Patients with a body mass index (BMI) of 30 or higher
US$ 23.33
US$ 22.96
US$ 25.91
US$ 22.63
US$ 21.52
